Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
1(13%)
Results Posted
33%(2 trials)

Phase Distribution

Ph phase_4
1
13%
Ph not_applicable
4
50%
Ph phase_2
2
25%
Ph phase_1
1
13%

Phase Distribution

1

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
1(12.5%)
Phase 2Efficacy & side effects
2(25.0%)
Phase 4Post-market surveillance
1(12.5%)
N/ANon-phased studies
4(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(1)
Completed(6)
Other(1)

Detailed Status

Completed6
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (12.5%)
Phase 22 (25.0%)
Phase 41 (12.5%)
N/A4 (50.0%)

Trials by Status

recruiting113%
completed675%
unknown113%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
8